danofloxacin has been researched along with elacridar in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fink-Gremmels, J; Schrickx, JA | 1 |
1 other study(ies) available for danofloxacin and elacridar
Article | Year |
---|---|
Danofloxacin-mesylate is a substrate for ATP-dependent efflux transporters.
Topics: Acridines; Adenosine Triphosphate; Anti-Bacterial Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Caco-2 Cells; Carrier Proteins; Chromatography, High Pressure Liquid; Culture Media; Cyclosporins; Diffusion Chambers, Culture; Fluorometry; Fluoroquinolones; Humans; Membrane Transport Proteins; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Propionates; Quinolines; Tetrahydroisoquinolines | 2007 |